AT
Allay Therapeutics develops targeted analgesic formulations specifically designed for post-surgical pain management, utilizing a proprietary delivery system to enhance absorption and efficacy. Their products aim to reduce opioid reliance and improve patient recovery outcomes following surgical procedures.
San Jose, United StatesFounded 2017
Updated 4 months ago
Funding
$132.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Allay Therapeutics develops targeted analgesic formulations specifically designed for post-surgical pain management, utilizing a proprietary delivery system to enhance absorption and efficacy. Their products aim to reduce opioid reliance and improve patient recovery outcomes following surgical procedures.